General Information of the Compound
| Compound ID |
CP0076228
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-(3H-benzimidazol-5-yl)-3-(cyclohexylmethyl)-1H-imidazo[4,5-b]pyrazin-2-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C19H20N6O
|
||||||||||||||||||
| Molecular Weight |
348.41
|
||||||||||||||||||
| Canonical SMILES |
O=c1[nH]c2ncc(nc2n1CC1CCCCC1)-c1ccc2nc[nH]c2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C19H20N6O/c26-19-24-17-18(25(19)10-12-4-2-1-3-5-12)23-16(9-20-17)13-6-7-14-15(8-13)22-11-21-14/h6-9,11-12H,1-5,10H2,(H,21,22)(H,20,24,26)
Show/Hide
|
||||||||||||||||||
| InChIKey |
ARAFZLNEXXVYMQ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Cell Viability or Cytotoxicity Assay
| Cell Line ID | Cell Line Name | Cell Line Organism | |
| CL000048 | PC-3 | Homo sapiens (Human) | 1 |
| 1 |
IC50 = 1160 nM
|
TI
LI
LO
TS
|
|
|---|---|---|---|